← Back to headlines
FDA Panel Narrowly Backs Four Peptides
An FDA panel has narrowly voted to back four peptides, bringing the stock of companies like Hims & Hers into the spotlight.
25 Jul, 10:01 — 25 Jul, 10:01
Sources
Showing 1 of 1 sources
Related Stories
Homeland Security Secretary’s Plane Makes Emergency Landing After Engine Failure
26m ago
Berkshire Hathaway Signals Long-Term Commitment to Japanese Trading Houses
35m ago
South Korean Utility Proposes $15 Billion Upfront Power Payment From Samsung
57m ago
Chevron Confirms Expansion of Oil Operations in Venezuela
1h ago